Gilead Sciences (GILD) Short term Debt (2009 - 2026)
Gilead Sciences (GILD) reported Short term Debt of $2.41 billion for Q2 2026, down 14.0% from $2.81 billion a year earlier but up 83.9% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Short term Debt (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences posted Short term Debt of $2.81 billion, up 54.7% from FY2024.
- Short term Debt has a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
- By year, Short term Debt came in at $1.82 billion in FY2024 (+0.9%), $1.8 billion in FY2023 (-20.9%), $2.27 billion in FY2022 (+49.9%) and $1.52 billion in FY2021 (-45.0%).
- Five-year quarterly Short term Debt spans a low of $1.02 billion in Q2 2022 and a high of $4.04 billion in Q2 2023.
- Year over year, Short term Debt gained in five of the last eight quarters, with growth averaging 9.5%.
- The high point for year-over-year Short term Debt in five years was Q2 2023 (growth of 295.4%); the low point was Q2 2024 (a decline of 55.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.31 billion (Q1 2026), $2.81 billion (Q4 2025) and $2.81 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Bn |
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 2.81 Bn |
| Sep 30, 2025 | 2.81 Bn |
| Jun 30, 2025 | 2.81 Bn |
| Mar 31, 2025 | 2.81 Bn |
| Dec 31, 2024 | 1.82 Bn |
| Sep 30, 2024 | 1.81 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 3.67 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.79 Bn |
| Jun 30, 2023 | 4.04 Bn |
| Mar 31, 2023 | 2.28 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.27 Bn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 2.51 Bn |
API Access
Gilead Sciences Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();